http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI9800956-B8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_835225927ddfc401b0df8e2e60cf61f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23c9828ca007556e2703cf9ddc8e9562
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
filingDate 1998-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c8fb6bcfa6a15eb777e197c2bcebfdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18e9e9c3ee4c7d8e6ef89b17ffffe02b
publicationDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI9800956-B8
titleOfInvention therapeutic composition that acts by inhibiting serine proteases
abstract "pharmaceutical composition that acts by inhibiting serine proteases, and, medicament" pharmaceutical compositions that act by inhibiting serine proteases, characterized in that they comprise, in association with any suitable excipient, at least one compound of general formula (i) below : r~ 6~r~ 7~p~ (o) - (chr5)~ m~ - (chr4)~ n~ - si (or~ 1~) (or~ 2~) (r~ 3~) (i ) in which R 1 and R 2 each independently represent a hydrogen atom or an alkyl group, R 3 represents a hydroxyl group, or an alkoxy group or an alkyl group, R 4 and R 5 each independently represent a hydrogen atom, a hydroxyl group, an alkyl group or a carboxylic acid function, R 6 and R 7 each independently represent an alkoxy group, n is an integer greater than or equal to 0 and less than or equal to 4, m is an integer strictly greater than 0 and less than or equal to 3.
priorityDate 1997-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 33.